Stock Price Quote

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE579.204 (+0.7 %)
PREV CLOSE ( ) 575.20
OPEN PRICE ( ) 575.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4078
TODAY'S LOW / HIGH ( )575.35 591.40
52 WK LOW / HIGH ( )450 737.8
NSE579.754.55 (+0.79 %)
PREV CLOSE( ) 575.20
OPEN PRICE ( ) 577.35
BID PRICE (QTY) 579.75 (101)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 307263
TODAY'S LOW / HIGH( ) 571.80 591.50
52 WK LOW / HIGH ( )402.55 738.1
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in / dasaradhi@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX

NEWS

23May Natco Pharma supports Columbia Univers
Natco Pharma has reiterated its commitment in supporting a clinical tria..
21May Cipla, Tata Power and Natco Pharma to
Cipla has received final approval for its Abbreviated New Drug Applicati..
21May Natco Pharma gets EIR from USFDA for f
Natco Pharma has received Establishment Inspection Report (EIR) from the..
28Apr Natco Pharma’s Vizag formulation facil
Natco Pharma has received final approval for its 1st supplemental Abbrev..
27Apr Granules India, BEML and IRB Infrastru
Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuti..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit10366671
Gross Profit 1273 8474
Operating Profit 15769463
Net Sales 447719863

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr. Reddys Lab (BSE)
peergroup  4073.80 (4.76%)
M.Cap ( in Cr)67695.18
Abbott India (BSE)
peergroup  16728.05 (0.80%)
M.Cap ( in Cr)35545.94
Astrazeneca Pharma I (BSE)
peergroup  3044.50 (4.52%)
M.Cap ( in Cr)7611.25
Divis Lab (BSE)
peergroup  2395.75 (4.92%)
M.Cap ( in Cr)63599.64
Solara Active Pharma (BSE)
peergroup  517.20 (9.70%)
M.Cap ( in Cr)1388.95

Shareholding Pattern

MUTUAL FUNDS/UTI 8.5%
PROMOTERS 48.93%
NON-INSTITUTION 18.83%
FI/BANKS/INSURANCE 1.06%
GOVERNMENT 0%
FII 0%

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 579.2. Its current market capitalisation stands at Rs 10545.38 Cr. In the latest quarter, company has reported Gross Sales of Rs. 20945 Cr and Total Income of Rs.22247 Cr. The company's management includes Sridhar Sankararaman, D Linga Rao, MUR Naidu, PSRK Prasad, Leela Digumarti, DG Prasad, Rajeev Nannapaneni, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X